Alzamend Neuro Cash Flow Statement 2019-2024 | ALZN

Fifteen years of historical annual cash flow statements for Alzamend Neuro (ALZN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
202420232022202120202019
$-9.95$-14.88$-12.36$-5.05$-4.41$-4.86
$0.05$0.02$0.00$0$0$-0.04
$0.96$3.58$4.42$2.49$2.26$2.62
$1.01$3.61$4.42$2.49$2.26$2.59
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0.62$0.64$0.63$0.26$-0.02$0.22
$0.67$2.35$1.33$-0.15$-0.19$1.23
$-8.27$-8.92$-6.61$-2.71$-2.35$-1.05
$-0.15$0$-0.11$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0$0$0
$0$0$0$0.10$0.23$0.23
$-0.15$0$-0.11$0.10$0.11$0.23
$0.30$0$-0.06$0.50$0.02$0
$0$0$0$1.85$-0.02$0.07
$0.30$0$-0.06$2.35$0.00$0.07
$1.25$0$6.00$2.10$2.29$0.24
$3.35$0$6.00$2.10$2.29$0.24
$0$0$0$0$0$0
$0$0.00$12.91$0$0$0
$3.65$0.00$18.86$4.45$2.29$0.31
$-4.76$-8.92$12.13$1.84$0.05$-0.50
$0.96$3.58$4.41$2.03$1.80$0.40
$0$0$0$0$0$0